12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Monday's intraday session, health care stocks saw significant movements. Sunshine Biopharma, Xilio Therapeutics, Akanda, Mesoblast, Brainstorm Cell, and Adagene were among the gainers with notable percentage increases in their stock prices. On the downside, Eiger BioPharmaceuticals, Disc Medicine, AEON Biopharma, Biora Therapeutics, Sharecare, and ENDRA Life Sciences experienced substantial declines. The movements were attributed to various factors including quarterly earnings reports for some companies.
April 01, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sunshine Biopharma's stock rose 86.3% to $0.11, with a market cap of $11.2 million.
The significant rise in Sunshine Biopharma's stock price could attract more investor interest in the short term, potentially maintaining or increasing the stock's upward momentum.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Xilio Therapeutics' stock increased by 25.93% to $1.36, with a market cap of $37.4 million.
Xilio Therapeutics' notable stock price increase suggests positive market sentiment which could lead to further short-term gains.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90
NEGATIVE IMPACT
AEON Biopharma's shares fell by 40.74% to $6.88, with a market cap of $255.4 million. The Q4 earnings were released yesterday.
The release of AEON Biopharma's Q4 earnings and the subsequent stock price drop could indicate investor disappointment, possibly affecting the stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Eiger BioPharmaceuticals' stock plummeted by 67.8% to $1.61, with a market cap of $2.3 million.
The drastic drop in Eiger BioPharmaceuticals' stock price could lead to negative sentiment among investors, potentially causing further short-term declines.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90